- Home
- UCL vs KRON Comparison
UCL vs KRON Comparison
Compare UCL & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- KRON
- Stock Information
- Founded
- UCL 2014
- KRON 2017
- Country
- UCL Hong Kong
- KRON United States
- Employees
- UCL N/A
- KRON N/A
- Industry
- UCL Telecommunications Equipment
- KRON Medicinal Chemicals and Botanical Products
- Sector
- UCL Consumer Discretionary
- KRON Health Care
- Exchange
- UCL Nasdaq
- KRON Nasdaq
- Market Cap
- UCL 48.7M
- KRON 57.8M
- IPO Year
- UCL 2020
- KRON 2020
- Fundamental
- Price
- UCL $2.13
- KRON $0.96
- Analyst Decision
- UCL
- KRON Buy
- Analyst Count
- UCL 0
- KRON 3
- Target Price
- UCL N/A
- KRON $1.63
- AVG Volume (30 Days)
- UCL 378.8K
- KRON 379.1K
- Earning Date
- UCL 11-26-2024
- KRON 11-13-2024
- Dividend Yield
- UCL N/A
- KRON N/A
- EPS Growth
- UCL 169.91
- KRON N/A
- EPS
- UCL 0.11
- KRON N/A
- Revenue
- UCL $87,405,000.00
- KRON $9,864,000.00
- Revenue This Year
- UCL $11.23
- KRON $62.21
- Revenue Next Year
- UCL $27.52
- KRON N/A
- P/E Ratio
- UCL $18.91
- KRON N/A
- Revenue Growth
- UCL 4.73
- KRON 146.48
- 52 Week Low
- UCL $0.97
- KRON $0.69
- 52 Week High
- UCL $3.30
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- UCL 62.21
- KRON 50.33
- Support Level
- UCL $1.41
- KRON $0.91
- Resistance Level
- UCL $3.30
- KRON $1.01
- Average True Range (ATR)
- UCL 0.39
- KRON 0.06
- MACD
- UCL 0.11
- KRON -0.01
- Stochastic Oscillator
- UCL 45.33
- KRON 32.94
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.